92 related articles for article (PubMed ID: 12777194)
1. A trial of adjuvant therapy in colorectal cancer: the VICTOR trial.
Pendlebury S; Duchesne F; Reed KA; Smith JL; Kerr DJ
Clin Colorectal Cancer; 2003 May; 3(1):58-60. PubMed ID: 12777194
[No Abstract] [Full Text] [Related]
2. VICTOR spoiled?
Goldberg RM; Bertagnolli MM
J Clin Oncol; 2010 Oct; 28(30):4546-8. PubMed ID: 20837951
[No Abstract] [Full Text] [Related]
3. Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer.
Kerr DJ; Dunn JA; Langman MJ; Smith JL; Midgley RS; Stanley A; Stokes JC; Julier P; Iveson C; Duvvuri R; McConkey CC;
N Engl J Med; 2007 Jul; 357(4):360-9. PubMed ID: 17652651
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer.
Maxwell-Armstrong C; Scholefield J
Clin Evid; 2002 Jun; (7):406-13. PubMed ID: 12230666
[No Abstract] [Full Text] [Related]
5. [Homeopathy suppresses COX- and LOX activity. Soft therapy for arthrosis ills].
MMW Fortschr Med; 2004 Jan; 146(5):47. PubMed ID: 15035421
[No Abstract] [Full Text] [Related]
6. [Adjuvant therapy of colorectal cancers].
Joensuu H; Kellokumpu I
Duodecim; 1997; 113(8):705-13. PubMed ID: 11466869
[No Abstract] [Full Text] [Related]
7. Colorectal cancer and Coxibs.
Taxonera C; Mendoza JL
Rev Esp Enferm Dig; 2004 Oct; 96(10):673-5; 675-7. PubMed ID: 15537373
[No Abstract] [Full Text] [Related]
8. [Regional adjuvant therapy in colorectal liver metastases: requirements for clinical therapy studies from the statistical viewpoint].
Müller HH; Schäfer H
Zentralbl Chir; 1995; 120(10):755-9. PubMed ID: 7502588
[TBL] [Abstract][Full Text] [Related]
9. [Problems of randomized controlled study on surgical adjuvant chemotherapy for colorectal cancer in Japan].
Kodaira S
Gan To Kagaku Ryoho; 1993 Dec; 20(16):2461-6. PubMed ID: 8279842
[TBL] [Abstract][Full Text] [Related]
10. [Meta-analysis on acute pain. Rofecoxib helped three quarters of patients].
MMW Fortschr Med; 2003 Aug; 145(31-32):57. PubMed ID: 14524084
[No Abstract] [Full Text] [Related]
11. Randomized multicenter trial of adjuvant intraportal chemotherapy for colorectal cancer (SAKK 40/81). An interim report.
Metzger U; Laffer U; Aeberhard P; Arigoni M; Arma S; Barras J; Egeli R; Martinoli S; Mueller W; Schweizer W
Acta Chir Scand; 1990; 156(6-7):467-74. PubMed ID: 2114722
[TBL] [Abstract][Full Text] [Related]
12. [Selective COX 2 inhibitor rofecoxib. To "defy" the pain].
MMW Fortschr Med; 2003 Aug; 145(31-32):56-7. PubMed ID: 14524083
[No Abstract] [Full Text] [Related]
13. [Colorectal cancers: adjuvant therapy and after care (including tumor markers)].
Laffer U; Harder F
Ther Umsch; 1991 Jul; 48(7):449-55. PubMed ID: 1926004
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.
Bresalier RS; Sandler RS; Quan H; Bolognese JA; Oxenius B; Horgan K; Lines C; Riddell R; Morton D; Lanas A; Konstam MA; Baron JA;
N Engl J Med; 2005 Mar; 352(11):1092-102. PubMed ID: 15713943
[TBL] [Abstract][Full Text] [Related]
15. [Chemopreventive agents in colorectal cancer].
Benamouzig R; Chaussade S
Rev Prat; 2003 Dec; 53(20):2213-4. PubMed ID: 15018072
[No Abstract] [Full Text] [Related]
16. Is the demonstration of adenoma reduction with rofecoxib a pyrrhic victory?
Lynch PM
Gastroenterology; 2006 Dec; 131(6):2003-5. PubMed ID: 17188962
[No Abstract] [Full Text] [Related]
17. [Rapid, strong and long-term effectiveness. Coxib also effective in toothache].
MMW Fortschr Med; 2003 Jan; 145(1-2):53. PubMed ID: 12638443
[No Abstract] [Full Text] [Related]
18. Comment on efficacy of rofecoxib and nimesulide in controlling post-extraction pain in oral surgery: a randomised comparative study.
Villa G
Curr Med Res Opin; 2004 Apr; 20(4):573-4; author reply 574. PubMed ID: 15119995
[No Abstract] [Full Text] [Related]
19. [New treatment of pain and fever in rheumatoid arthritis and arthrosis. The first cyclooxygenase-2 inhibitors show promising results].
Oliw E; Wollheim FA
Lakartidningen; 2000 Jun; 97(24):2942-4. PubMed ID: 10900877
[No Abstract] [Full Text] [Related]
20. Rofecoxib: a new selective COX-2 inhibitor.
Rajadhyaksha VD; Dahanukar SA
J Postgrad Med; 2001; 47(1):77-8. PubMed ID: 11590304
[No Abstract] [Full Text] [Related]
[Next] [New Search]
